U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782216) titled 'Critical Hyperacute Assessment Research On Neurobiomarker Kinetics in Acute Brain Injury' on Aug. 12.
Brief Summary: Traumatic brain injury (TBI) and other conditions that reduce blood flow to the brain - such as cardiac arrest (CA) - are life-threatening medical emergencies. When brain cells are damaged, they release specific proteins into the bloodstream. These proteins, called neurobiomarkers, can be measured in blood samples and may help doctors assess the severity of brain injury, guide treatment, and predict patient outcomes.
A major gap in current knowledge is how these neurobiomarkers behave during the very first minutes an...